Stock Picks: Demand for COVID-19 Vaccines (NVAX)

April 26, 2021, 6:53 pm EDT

Demand for COVID-19 Vaccines (NVAX)

When India cases rose 300K-400K in recent days and the death toll spiked up, it is essential to ask this question: where are the vaccines? We made a trader NVAX +122% Profits two months ago. NVAX made a two-month convergence pattern and now the setup is completed.  

Breaking out 225 could offer an entry point to ride NVAX again with a sell-stop at 200.

Share This Post
Have your say!

Leave a Reply